Heteroaryl derivative compounds and uses thereof

JP2024519626A5Active Publication Date: 2025-03-25VORONOI INC

0 Cites 0 Cited by

Patent Information

Application Number: JP2022573567
Authority / Receiving Office: JP · JP
Patent Type: Applications
Current Assignee / Owner
Priority Date: 2021-05-17
Filing Date: 2022-05-16
Publication Date: 2025-03-25
Estimated Expiration: 2042-05-16

Application Information

Patent Timeline

17 May 2021

Priority

16 May 2022

Application

JP2022573567

25 Mar 2025

Publication

JP2024519626A5

IPC: C07D413/04; A61P43/00; A61P35/00; A61P35/02; A61P35/04; A61K31/506; C07D413/14; A61K31/5377; C07D471/04; A61K31/541; A61K31/5383; C07D498/04; C07D487/04; A61K31/4995; C07D487/08; A61K31/5386; C07D491/08; A61K31/551; A61K31/675; C07D471/10; A61K31/496; C07D487/10; C07F9/6584

CPC: C07D413/04; A61K31/495; A61K31/5377; A61K31/506; A61K31/55; A61K31/541; A61P35/00; C07D413/14

Inventors: イ,ユンホ; ファン,ソンア

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Abstract

The present invention relates to a heteroaryl derivative and its use. The heteroaryl derivative of the present invention exhibits excellent inhibitory activity against EGFR and / or HER2, and can therefore be usefully used as a therapeutic agent for the EGFR and / or HER2-related diseases.

Need to check novelty before this filing date? Find Prior Art